ASHLEY MOLE: Open Payments
NPI 1548851173 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 22 payments from 9 companies in 2025. Trend: 2023 $520 · 2024 $652 · 2025 $455
Food & beverage: $368Education: $87
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $170 |
| ABBVIE INC. | 6 | $97 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Ardelyx, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: TREMFYA, RINVOQ, LINZESS, VOQUEZNA, XIFAXAN, IBSRELA, DUPIXENT, VELSIPITY.
Industry payments across FL — which companies pay providers there.
